Connectome Health
Builds AI-enabled neurotechnology that tracks brain changes in real time to support clinical monitoring, diagnosis and research into neurological conditions.
Overview
Connectome Health develops AI-enabled neurotechnology aimed at measuring and tracking brain changes in real time. Based in Zurich, the company positions its offering at the intersection of neuroscience, clinical monitoring and research, with an emphasis on delivering continuous, time-resolved neural metrics rather than static snapshots. The company closed a $2M pre-seed on 2026-04-01 led by Redstone and has raised $2M in total. The funding announcement highlights its focus on real-time brain-change tracking; no additional technical specifications, commercial partnerships or customers were disclosed in the round coverage.
Funding History
Redstone leads $2M pre-seed for Zurich neurotech Connectome Health to track brain changes in real time
Frequently Asked Questions
- How much funding does AI Funding track for Connectome Health?
- AI Funding tracks $2M for Connectome Health across 1 funding round in this database.
- Who are Connectome Health's investors?
- Connectome Health's investors include Redstone, Concept Ventures, Octopus.
- What does Connectome Health do?
- Connectome Health develops AI-enabled neurotechnology aimed at measuring and tracking brain changes in real time. Based in Zurich, the company positions its offering at the intersection of neuroscience, clinical monitoring and research, with an emphasis on delivering continuous, time-resolved neural metrics rather than static snapshots. The company closed a $2M pre-seed on 2026-04-01 led by Redstone and has raised $2M in total. The funding announcement highlights its focus on real-time brain-change tracking; no additional technical specifications, commercial partnerships or customers were disclosed in the round coverage.
- Where is Connectome Health headquartered?
- Connectome Health is headquartered in Zurich, Switzerland.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.